SAT0326 Duration of remission and minimal disease activityafter starting and discontinuation of biologic (B) dmards in early psoriatic arthritis patients treated according to treat-to-target strategy (results of an open-label remarca study)

Abstract

BackgroundThe main goal of treat-to-target (T2T) strategy in psoriatic arthritis (PsA) is achievement of remission (REM) or minimal disease activity (MDA). There is limited data concerning the duration of REM/MDA...